Bai Ren Medical: plans to repurchase shares worth 50 million to 100 million yuan for incentives.

Bairen Medical announced that on June 10th, the company's board of directors approved a share repurchase plan. The company plans to repurchase shares with its own funds in the amount of 50 million to 100 million RMB through centralized bidding trading method, for the purpose of employee stock ownership plan or equity incentives. The repurchase price shall not exceed 139.05 RMB per share, with a term of 12 months from the date of approval by the board. It is estimated that 359,583 to 719,165 shares will be repurchased, accounting for 0.26% to 0.52% of the total share capital. As of the disclosure date, there are no plans for shareholders to reduce their holdings. This repurchase plan involves various uncertainties and risks.